Skip to main content
Clinical Trials/NL-OMON30564
NL-OMON30564Not yet recruitingPhase 4

The use of USPIO enhanced MRI in the assessment of axillary lymph node status in patients with invasive breast cancer - The USPALS study

niversitair Medisch Centrum Sint Radboud0 sites440 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
440

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Histologically proven invasive breast cancer
  • - Surgical removal of at least 1 axillary lymph node will be performed
  • - Patient must be accessible for treatment
  • - Patient must provide written informed consent

Exclusion Criteria

  • - Patient age < 18
  • - Karnofsky score = 70 or <70
  • - Pregnant or lactating women
  • - Patients with conta-indications for MRI scanning (e.g. pacemaker, claustrophobia, ferromagnetic objects in the eyes or brain)
  • - Patients with contra-indications for the use of USPIO based contrast agents or dextran (e.g. known allergy)
  • - Male gender

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Similar Trials